Risk Partners Life Sciences Roundtable 2024, thank you very much! Sign up now for the 26.06.2025 >

Contact us

Growth capital for biotechnology
and life sciences - Finance Day 2024

A few days ago, Jutta and Florian from our team attended Finance Day 2024 at the analytica trade fair in Munich. The event once again offered exciting expert panels on current financing and capital market issues for life sciences companies. As the panels focused on three of our key consulting areas, namely life sciences, venture capital and IPOs, attending was of course a must for us as a specialist insurance broker. Our team was also delighted to meet many of our partners and clients again and talk to them about the importance of risk management and insurance solutions.

The startup panel was also interesting and once again demonstrated the innovative spirit of the industry. Ten companies were selected for this, nine of which were even presented in person by a founder. Take a look at the companies and if you are interested in the product or an investment, please contact the ladies or gentlemen directly. We are keeping our fingers crossed! 

  1. Better Basics Laborbedarf GmbH(Mario Schneider)
  2. Intu Diagnostics GmbH(Dr. Dirk Kuhlmeier )
  3. Pacifico Biolabs GmbH(Washington Logroño)
  4. Dr. Purus Enorm Smart Technik GmbH(Dr. Bo Liu)
  5. goodBot GmbH(Dr. Julius Wiener)
  6. hema.to GmbH(Dr. Karsten Miermanns)
  7. IRUBIS GmbH(Anja Müller)
  8. Opto Biolabs GmbH(Dr. Kathrin Brenker)
  9. Safia Technologies GmbH(Dr. Timm Schwaar)
  10. CamSens GmbH(Enrika Barreto) 
Risk Partners at the Finance Days
Flyer Finance Days 2024

In addition, the challenges of the financing environment were again discussed from various perspectives. The desire for a European capital market that would combine the strengths of Frankfurt, Euronext and NASDAQ Europe was articulated fairly unanimously. From our point of view as a specialist insurance broker, this is also desirable, although the standardization of the liability framework would certainly become even more challenging, so that different solutions for each stock exchange would no longer be necessary, as is currently the case.  

In conclusion, we are delighted to have been part of these events and will be back at the next one in Leipzig. Thanks also to the team of Plattform Life Sciences and Going Public Media AG for the great organization and the successful framework of the event! We had a lot of fun. 

Also read our other blog posts

Being Public

Prospectus liability insurance (POSI): Risk Partners publishes for you

Risk Partners on Going Public and the capital market blog on prospectus liability insurance In recent months, we have been able to share our expertise on prospectus liability insurance with a wide audience on two renowned platforms. Here is an overview: Kapitalmarkt.blog In the article "POSI insurance - The protective vest on the capital market", we explain why prospectus liability insurance is an indispensable tool for companies becoming active on the capital market. The article shows in a practical way how such insurance not only minimizes liability risks, but also strengthens investor confidence. GoingPublic Magazine In

Read more "
December 29, 2024
4 pillars of cyber insurance for venture capital and private equity
Cyber Security

Cyber insurance Venture capital and private equity

Why cyber insurance does not transfer the core risk of VC & PE funds and why we have invested in Risk Partners cyber master agreements. Why cyber risks are relevant for venture capital and private equity funds With the increasing growth of the cyber crime industry (see Federal Office for the Protection of the Constitution), venture capital (VC) and private equity (PE) funds and their fund managers are also increasingly exposed to cyber risks. For years, this has been reflected in the claims we have been able to support, in which fund managers have ranked first year after year among the industries we advise.

Read more "
December 29, 2024
Cyber Security

"Digital Operational Resilience Act" (DORA regulation) from the perspective of venture capital and private equity funds

DORA regulation applies from January 2025. Significance for our private equity and venture capital clients The somewhat unwieldy name "Digital Operational Resilience Act" (DORA for short) has a very serious background and is fundamentally to be welcomed. After all, when we evaluate our claims in the context of cybercrime, PE and VC funds and their KVGs are those with the highest frequency of claims. It can be safely assumed that they are a "worthwhile target group" for cyber criminals based abroad.

Read more "
December 27, 2024
Your question has not been answered?
We will be happy to advise you in a free initial consultation.
Get advice now

Receive the Life Sciences Insurance Protection Guide free of charge!

Everything you need to know to optimally protect you and your life sciences / biotech company.